165 related articles for article (PubMed ID: 1605610)
21. The antibacterial activity of ticarcillin/clavulanic acid (BRL28500) against ticarcillin-resistant bacteria.
Kasai T; Nishino T; Kazuno Y; Tanino T
J Antibiot (Tokyo); 1986 Oct; 39(10):1450-60. PubMed ID: 3536827
[TBL] [Abstract][Full Text] [Related]
22. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
[TBL] [Abstract][Full Text] [Related]
23. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
24. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
Branger C; Kitzis M; Le Mée J
Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
[TBL] [Abstract][Full Text] [Related]
25. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
Cuffini AM; Tullio V; Paizis G; Carlone NA
J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
Fuchs PC; Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
[TBL] [Abstract][Full Text] [Related]
27. Development of beta-lactamase inhibitors.
Sutherland R
J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
[TBL] [Abstract][Full Text] [Related]
28. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
29. Implications of beta-lactamase-inhibitor combinations.
Fuchs PC; Barry AL
J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
[TBL] [Abstract][Full Text] [Related]
30. Beta-lactam resistance in Campylobacter coli and Campylobacter jejuni chicken isolates and the association between bla
Casagrande Proietti P; Guelfi G; Bellucci S; De Luca S; Di Gregorio S; Pieramati C; Franciosini MP
Vet Microbiol; 2020 Feb; 241():108553. PubMed ID: 31928700
[TBL] [Abstract][Full Text] [Related]
31. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
32. Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.
Fuchs PC; Jones RN; Barry AL
J Clin Microbiol; 1989 Nov; 27(11):2475-81. PubMed ID: 2808671
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
34. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
Cantoni L; Wenger A; Glauser MP; Bille J
J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
[No Abstract] [Full Text] [Related]
37. Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.
Smith GM; Abbott KH; Wilkinson MJ; Beale AS; Sutherland R
Antimicrob Agents Chemother; 1991 Jul; 35(7):1423-9. PubMed ID: 1929303
[TBL] [Abstract][Full Text] [Related]
38. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Chambers HF; Sachdeva M; Kennedy S
J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
Cantoni L; Glauser MP; Bille J
Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
[TBL] [Abstract][Full Text] [Related]
40. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]